In a recent interview with BioVox, Alberto Noronha, Ph.D., CEO of Luxembourg-based biotech startup NIUM, delves into the powerful connection between the gut microbiome and human health. As we face a modern era of overnutrition yet undernourishment, Noronha highlights the growing importance of understanding how our diet and various compounds impact the trillions of microbes in our gut.
Noronha explains how NIUM is revolutionizing this space with their innovative “gut-on-a-chip” technology. This system enables companies to better study the effects of food ingredients, supplements, and pharmaceuticals on gut health, helping accelerate the development of nutritious products. NIUM’s cutting-edge approach to microbiome research is poised to unlock critical insights, from how foods influence microbial diversity to their potential role in preventing diseases like obesity and Alzheimer’s.
With growing interest in gut health and the probiotics market now exceeding $70 billion, NIUM is at the forefront of using technology to develop healthier, evidence-based solutions. Situated in Luxembourg’s thriving biotech ecosystem, NIUM is well-positioned to drive the next frontier of health innovation.
Read the full interview here.
This summary should capture the essence of the interview and encourage readers to explore the full content.